Header Logo

SHREYASKUMAR PATEL

TitleProfessor
InstitutionMD Anderson
DepartmentSarcoma Medical Oncology
Address1400 Holcombe Blvd
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nakazawa MS, Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel SR, Conley AP, Roland CL, Soliman PT, Beird HC, Wu CC, Ingram DR, Lazcano R, Song D, Wani KM, Lazar AJ, Yap TA, Wang WL, Livingston JA. Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Mol Cancer Ther. 2024 Apr 02. PMID: 38561019.
      Citations:    Fields:    
    2. Thirasastr P, Sutton TL, Joseph CP, Lin H, Amini B, Mayo SC, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Nassif Haddad EF, Nakazawa MS, Zhou X, Heinrich MC, Somaiah N. Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter? Cancers (Basel). 2024 Feb 23; 16(5). PMID: 38473266; PMCID: PMC10931337.
      Citations:    
    3. Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah N. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Feb 13. PMID: 38351182.
      Citations:    Fields:    
    4. Denu RA, Yang RK, Lazar AJ, Patel SS, Lewis VO, Roszik J, Livingston JA, Wang WL, Shaw KR, Ratan R, Zarzour MA, Bird J, Raza SM, Akdemir KC, Rodon Ahnert J, Subbiah V, Patel S, Conley AP, Denu RA, Yang RK, Lazar AJ, Patel SS, Lewis VO, Roszik J, Livingston JA, Wang WL, Shaw KR, Ratan R, Zarzour MA, Bird J, Raza S, Akdemir KC, Rodon Ahnert J, Subbiah V, Patel S, Conley AP. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes. Clin Cancer Res. 2023 12 01; 29(23):4844-4852. PMID: 37747813; PMCID: PMC10835757.
      Citations:    Fields:    Translation:Humans
    5. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718. PMID: 37058010; PMCID: PMC10150251.
      Citations:    Fields:    Translation:Humans
    6. Nguyen J, Takebe N, Kummar S, Razak A, Chawla SP, George S, Patel SR, Keohan ML, Movva S, O'Sullivan Coyne G, Do K, Juwara L, Augustine B, Steinberg SM, Kuhlmann L, Ivy SP, Doroshow JH, Chen AP. Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma. Clin Cancer Res. 2023 04 03; 29(7):1200-1208. PMID: 36302173; PMCID: PMC10068440.
      Citations: 1     Fields:    Translation:Humans
    7. Moyers JT, Pestana RC, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap TA, Karp D, Rodon J, Livingston A, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res. 2023 01 17; 29(2):401-409. PMID: 36288393; PMCID: PMC9843435.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    8. Silvia S, Hans Roland D, Inga-Marie S, Klaus W, Rick H, Annalisa T, Augusto C, Jyoti B, Giacomo Giulio B, Nicholas B, Jean-Yves B, Kjetil B, Javier-Martin B, Wei-Wu Tom C, Tos Paolo Angelo D, Jayesh D, Stephan E, Mikael E, Alessandro G, Hans G, Jendrik H, Wolfgang H, John H, Antoine I, Jones Robin L, Akira K, Andreas L, Herbert L, Eric M, Carlo M, Nadine O, Emanuela P, Shreyaskumar R P, Peter R, Brian R, Piotr R, Claudia S, Kathrin S, Seddon Beatrice M, Morena S, Staals Eric L, William T, Vanhoenacker Filip MM, Andrew W, Lisette W, Sydney S, de Sande Michiel V, Sebastian B. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts. Cancer Treat Rev. 2022 Dec 06; 112:102491. PMID: 36502615.
      Citations: 2     Fields:    
    9. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol. 2022; 12:1008484. PMID: 36313661; PMCID: PMC9597628.
      Citations: 2     
    10. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med. 2023 02; 12(4):4282-4293. PMID: 36151848; PMCID: PMC9972024.
      Citations: 2     Fields:    Translation:Humans
    11. Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent JC, Ravi V, Patel S, Wilky BA. Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. Clin Cancer Res. 2022 09 15; 28(18):4092-4104. PMID: 35180772; PMCID: PMC9475245.
      Citations:    Fields:    
    12. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol. 2022 09; 23(9):1156-1166. PMID: 35934010.
      Citations:    
    13. Bishop AJ, Amini B, Lin H, Raza SM, Patel S, Grosshans DR, Ghia A, Farooqi A, Guadagnolo BA, Mitra D, Akdemir KC, Lazar AJ, Wang WL, Alvarez-Breckenridge C, Bird J, Rhines LD, Somaiah N, Conley AP. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother. 2022 10 01; 45(8):374-378. PMID: 35943386; PMCID: PMC9452485.
      Citations:    
    14. Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Mennel RG, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen B, Piha-Paul SA, Patel AB, Lazar AJ, Conley AP, Benjamin RS, Patel SR, Futreal PA, Somaiah N, Naing A. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer. 2022 09 15; 128(18):3383-3391. PMID: 35792683.
      Citations:    Fields:    
    15. D'Angelo SP, Conley AP, Dickson MA, Gounder M, Kelly C, Keohan ML, Movva S, Thornton K, Rosenbaum E, Chi P, Nacev B, Chan JE, Slotkin EK, Kiesler H, Adamson T, Patel S, Livingston JA, Singer S, Agaram NP, Antonescu CR, Koff A, Erinjeri JP, Hwang S, Qin LX, Tap WD, Richards AL, Woo HJ, Ling L, Rao P, Donoghue MTA. Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma. Nat Commun. 2022 06 16; 13(1):3477. PMID: 35710741; PMCID: PMC9203519.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    16. Bishop AJ, Zheng J, Subramaniam A, Ghia AJ, Wang C, McGovern SL, Patel S, Guadagnolo BA, Mitra D, Farooqi A, Reardon MJ, Kim B, Guha-Thakurta N, Li J, Ravi V. Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention. Am J Clin Oncol. 2022 06 01; 45(6):258-263. PMID: 35588225; PMCID: PMC9179017.
      Citations:    Fields:    Translation:Humans
    17. Avutu V, Weiss AR, Reed DR, Ahmed SK, Allen-Rhoades WA, Chen YE, Davis LE, Eaton BR, Hawkins DS, Indelicato DJ, Patel SR, Randall RL, Reinke DK, Riedel RF, Scharschmidt TJ, Thornton KA, Wang D, Janeway KA, Kopp LM. Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321. J Adolesc Young Adult Oncol. 2022 06; 11(3):328-332. PMID: 34515544; PMCID: PMC9354033.
      Citations:    Fields:    Translation:Humans
    18. Kang YK, George S, Jones RL, Rutkowski P, Shen L, Mir O, Patel S, Zhou Y, von Mehren M, Hohenberger P, Villalobos V, Tap WD, Trent J, Pantaleo MA, He K, Hew P, Newberry K, Roche M, Heinrich MC, Bauer S, Brahmi M, Sch?ffski P. Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. J Clin Oncol. 2021 10 01; 39(28):3128-3139. PMID: 34343033; PMCID: PMC8478403.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    19. Patel SR, Reichardt P. An updated review of the treatment landscape for advanced gastrointestinal stromal tumors. Cancer. 2021 07 01; 127(13):2187-2195. PMID: 33974733; PMCID: PMC8252111.
      Citations: 2     Fields:    Translation:Humans
    20. Piha-Paul SA, Dumbrava EE, Nair BC, Xiong W, Xu L, Mostorino R, Subbiah V, Tannir N, Fu S, Naing A, Janku F, Karp DD, Patel S, Daw NC, Hong D, Meric-Bernstam F, Zinner R. A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies. Onco Targets Ther. 2021; 14:3037-3049. PMID: 33994796; PMCID: PMC8114359.
      Citations: 2     Translation:CTClinical Trials
    21. Jones RL, Herzog TJ, Patel SR, von Mehren M, Schuetze SM, Van Tine BA, Coleman RL, Knoblauch R, Triantos S, Hu P, Shalaby W, McGowan T, Monk BJ, Demetri GD. Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021 06; 10(11):3565-3574. PMID: 33960681; PMCID: PMC8178483.
      Citations: 1     Fields:    Translation:Humans
    22. Stacchiotti S, Frezza AM, Blay JY, Baldini EH, Bonvalot S, Callegaro D, Casali PG, Chiang RC, Demetri GD, Demicco EG, Desai J, Eriksson M, Gelderblom H, George S, Gounder MM, Gronchi A, Gupta A, Haas RL, Hayes-Jardon A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Lim J, Maestro R, Marcos-Gragera R, Martin Broto J, Matsuda T, Mir O, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Sundby Hall K, Tap WD, Thomas DM, van der Graaf WTA, van Houdt WJ, Visser O, von Mehren M, Wagner AJ, Wilky BA, Won YJ, Fletcher CDM, Dei Tos AP, Trama A, Bov?e JVMG, Chirlaque L?pez MD. Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. Cancer. 2021 08 15; 127(16):2934-2942. PMID: 33910263; PMCID: PMC8319065.
      Citations: 6     Fields:    Translation:Humans
    23. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat. 2021 Apr; 186(3):871-882. PMID: 33575859.
      Citations: 2     Fields:    Translation:Humans
    24. George S, Jones RL, Bauer S, Kang YK, Eskens F, Mir O, Serrano C, Tap WD, Trent J, Rutkowski P, Patel S, Chawla SP, Meiri E, Gordon M, Zhou T, Roche M, Heinrich MC, von Mehren M, Sch?ffski P, Cassier PA. Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy. Oncologist. 2021 04; 26(4):e639-e649. PMID: 33453089; PMCID: PMC8018324.
      Citations: 3     Fields:    Translation:Humans
    25. Traylor JI, Sheppard HE, Ravikumar V, Breshears J, Raza SM, Lin CY, Patel SR, DeMonte F. Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma. Neurosurgery. 2021 01 13; 88(2):428-436. PMID: 33017025; PMCID: PMC7803434.
      Citations:    Fields:    Translation:HumansAnimals
    26. Boyce-Fappiano D, Guadagnolo BA, Ratan R, Wang WL, Wagner MJ, Patel S, Livingston JA, Lin PP, Diao K, Mitra D, Farooqi A, Lazar AJ, Roland CL, Bishop AJ. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma. Oncologist. 2021 03; 26(3):250-260. PMID: 33289298; PMCID: PMC7930399.
      Citations: 3     Fields:    Translation:Humans
    27. Gounder MM, Merriam P, Ratan R, Patel SR, Chugh R, Villalobos VM, Thornton M, Van Tine BA, Abdelhamid AH, Whalen J, Yang J, Rajarethinam A, Duh MS, Bobbili PJ, Huynh L, Totev TI, Lax AK, Agarwal S, Demetri GD. Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma. Cancer. 2021 04 15; 127(8):1311-1317. PMID: 33296083; PMCID: PMC8247010.
      Citations: 3     Fields:    Translation:Humans
    28. Chugh R, Ballman KV, Helman LJ, Patel S, Whelan JS, Widemann B, Lu Y, Hawkins DS, Mascarenhas L, Glod JW, Ji J, Zhang Y, Reinke D, Strauss SJ. SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma. Cancer. 2021 04 15; 127(8):1301-1310. PMID: 33289920; PMCID: PMC8246769.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    29. Tarek N, Said R, Andersen CR, Suki TS, Foglesong J, Herzog CE, Tannir NM, Patel S, Ratan R, Ludwig JA, Daw NC. Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers (Basel). 2020 Oct 11; 12(10). PMID: 33050651; PMCID: PMC7599660.
      Citations:    
    30. Martin-Broto J, Hindi N, Eriksson M, Gronchi A, Kasper B, Maki R, Ortiz-Cruz EJ, Palmerini E, Patel S, Moura DS, Stacchiotti S, Valverde CM, Waisberg F, Aguiar S, Badilla-Gonz?lez R, Castro-Oliden V, Chac?n M, Correa-Generoso R, de ?lava E, Donati DM, Falla-Jimenez M, German G, Gobo Silva ML, Gouin F, Haro-Varas JC, Jim?nez-Brenes N, Lopes de Mello CA, Mart?nez-Delgado P, Mart?nez-Said H, Martinez-Tlahuel JL, Morales-P?rez JM, Mu?oz-Casares FC, Nakagawa SA, Sunyach MP, Blay JY. Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic. Oncologist. 2020 10; 25(10):e1562-e1573. PMID: 32888360; PMCID: PMC7543334.
      Citations: 3     Fields:    Translation:HumansCells
    31. Amin HM, Morani AC, Daw NC, Lamhamedi-Cherradi SE, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin RS, Patel S, Song J, Lazar AJ, Wang WL, Kurzrock R, Pappo A, Anderson PM, Schwartz GK, Araujo D, Cuglievan B, Ratan R, McCall D, Mohiuddin S, Livingston JA, Molina ER, Naing A, Ludwig JA. IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers. Cancers (Basel). 2020 Jul 02; 12(7). PMID: 32630797; PMCID: PMC7408058.
      Citations: 10     
    32. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma. 2020; 2020:8363986. PMID: 32565716; PMCID: PMC7285404.
      Citations: 6     
    33. Groisberg R, Roszik J, Conley AP, Lazar AJ, Portal DE, Hong DS, Naing A, Herzog CE, Somaiah N, Zarzour MA, Patel S, Brown RE, Subbiah V. Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies. Mol Cancer Ther. 2020 05; 19(5):1165-1172. PMID: 32127467; PMCID: PMC8386165.
      Citations: 4     Fields:    Translation:Humans
    34. Kairemo K, Santos EB, Macapinlac HA, Patel S, Conley AP, Hong DS, Subbiah AV. Molecular Imaging with 3'-deoxy-3'[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study. Diagnostics (Basel). 2020 Feb 25; 10(3). PMID: 32106426; PMCID: PMC7151088.
      Citations: 1     
    35. Wu CC, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang WL, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun. 2020 02 21; 11(1):1008. PMID: 32081846; PMCID: PMC7035358.
      Citations: 59     Fields:    Translation:Humans
    36. Bishop AJ, Bird JE, Conley AP, Roland CL, Moon BS, Satcher RL, Livingston JA, Patel S, Wang WL, Lazar AJ, Lewis VO, Lin PP, Guadagnolo BA. Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control. Am J Clin Oncol. 2019 10; 42(10):744-748. PMID: 31436747; PMCID: PMC7771031.
      Citations: 5     Fields:    Translation:Humans
    37. Jones RL, Maki RG, Patel SR, Wang G, McGowan TA, Shalaby WS, Knoblauch RE, von Mehren M, Demetri GD. Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin. Cancer. 2019 Dec 15; 125(24):4435-4441. PMID: 31503332; PMCID: PMC6916570.
      Citations: 4     Fields:    Translation:Humans
    38. Choy E, Ballman K, Chen J, Dickson MA, Chugh R, George S, Okuno S, Pollock R, Patel RM, Hoering A, Patel S. Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy". Sarcoma. 2019; 2019:7608743. PMID: 31534435; PMCID: PMC6732588.
      Citations: 1     
    39. Patel S, von Mehren M, Reed DR, Kaiser P, Charlson J, Ryan CW, Rushing D, Livingston M, Singh A, Seth R, Forscher C, D'Amato G, Chawla SP, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Demetri GD. Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma. Cancer. 2019 08 01; 125(15):2610-2620. PMID: 31173362; PMCID: PMC6771856.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    40. Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J. MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers (Basel). 2019 May 15; 11(5). PMID: 31096717; PMCID: PMC6562561.
      Citations: 10     
    41. Jones RL, Chawla SP, Attia S, Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC, Patel S, Wagner AJ, Chugh R, Heyburn JW, Weil SC, Wang W, Viele K, Maki RG, Sch?ffski P. A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas. Cancer. 2019 07 15; 125(14):2445-2454. PMID: 31034598; PMCID: PMC6618088.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    42. Bishop AJ, Livingston JA, Araujo DM, Moon BS, Patel S, Wang WL, Lazar AJ, Roland CL, Guadagnolo BA. Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery. Am J Clin Oncol. 2019 03; 42(3):238-242. PMID: 30614820.
      Citations: 3     Fields:    Translation:Humans
    43. Choy E, Ballman K, Chen J, Dickson MA, Chugh R, George S, Okuno S, Pollock R, Patel RM, Hoering A, Patel S. SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy. Sarcoma. 2018; 2018:2068517. PMID: 30473623; PMCID: PMC6220374.
      Citations: 4     
    44. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913. PMID: 30249211; PMCID: PMC6154892.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    45. van Maldegem A, Conley AP, Rutkowski P, Patel SR, Lugowska I, Desar IME, Gelderblom H, Bov?e JVMG. Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma. Oncologist. 2019 01; 24(1):110-116. PMID: 30082492; PMCID: PMC6324625.
      Citations: 12     Fields:    Translation:Humans
    46. Subbiah V, Lamhamedi-Cherradi SE, Cuglievan B, Menegaz BA, Camacho P, Huh W, Ramamoorthy V, Anderson PM, Pollock RE, Lev DC, Qiao W, McAleer MF, Benjamin RS, Patel S, Herzog CE, Daw NC, Feig BW, Lazar AJ, Hayes-Jordan A, Ludwig JA. Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clin Cancer Res. 2018 10 01; 24(19):4865-4873. PMID: 29871905; PMCID: PMC6168359.
      Citations: 23     Fields:    Translation:Humans
    47. Schuetze SM, Bolejack V, Thomas DG, von Mehren M, Patel S, Samuels B, Choy E, D'Amato G, Staddon AP, Ganjoo KN, Chow WA, Rushing DA, Forscher CA, Priebat DA, Loeb DM, Chugh R, Okuno S, Reinke DK, Baker LH. Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib. JAMA Oncol. 2018 06 01; 4(6):814-820. PMID: 29710216; PMCID: PMC6145709.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    48. Dirks MS, Patel S, Boriani S, Luzzati A, Fehlings MG, Fisher CG, Dekutoski MB, Williams R, Quraishi NA, Gokaslan ZL, Bettegowda C, Germscheid NM, Varga PP, Rhines LD, AOSpine Knowledge Forum Tumor, Charest-Morin R. Ewing Sarcoma of the Spine: Prognostic Variables for Survival and Local Control in Surgically Treated Patients. Spine (Phila Pa 1976). 2018 05 01; 43(9):622-629. PMID: 28837533.
      Citations: 3     Fields:    Translation:Humans
    49. Ferrari A, Bleyer A, Patel S, Chiaravalli S, Gasparini P, Casanova M. The challenge of the management of adolescents and young adults with soft tissue sarcomas. Pediatr Blood Cancer. 2018 07; 65(7):e27013. PMID: 29493075.
      Citations: 6     Fields:    Translation:Humans
    50. Kumar R, Kumar M, Malhotra K, Patel S. Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment. Curr Oncol Rep. 2018 02 28; 20(2):13. PMID: 29492676.
      Citations: 29     Fields:    Translation:Humans
    51. Groisberg R, Hong DS, Behrang A, Hess K, Janku F, Piha-Paul S, Naing A, Fu S, Benjamin R, Patel S, Somaiah N, Conley A, Meric-Bernstam F, Subbiah V. Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials. J Immunother Cancer. 2017 12 19; 5(1):100. PMID: 29254498; PMCID: PMC5735899.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    52. Menegaz BA, Cuglievan B, Benson J, Camacho P, Lamhamedi-Cherradi SE, Leung CH, Warneke CL, Huh W, Subbiah V, Benjamin RS, Patel S, Daw N, Hayes-Jordan A, Ludwig JA. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor. Oncologist. 2018 03; 23(3):360-366. PMID: 29212731; PMCID: PMC5905685.
      Citations: 16     Fields:    Translation:Humans
    53. Dembla V, Groisberg R, Hess K, Fu S, Wheler J, Hong DS, Janku F, Zinner R, Piha-Paul SA, Ravi V, Benjamin RS, Patel S, Somaiah N, Herzog CE, Karp DD, Roszik J, Meric-Bernstam F, Subbiah V. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Sci Rep. 2017 11 21; 7(1):15963. PMID: 29162825; PMCID: PMC5698336.
      Citations: 14     Fields:    Translation:HumansCells
    54. Groisberg R, Roszik J, Conley A, Patel SR, Subbiah V. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope. Curr Oncol Rep. 2017 Oct 13; 19(12):78. PMID: 29030741.
      Citations: 12     Fields:    Translation:Humans
    55. Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 11; 18(11):1493-1501. PMID: 28988646; PMCID: PMC7939029.
      Citations: 359     Fields:    Translation:HumansCTClinical Trials
    56. Quintana RA, Banchs J, Gupta R, Lin HY, Raj SD, Conley A, Ravi V, Araujo D, Benjamin RS, Patel S, Vadhan-Raj S, Somaiah N. Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion. Sarcoma. 2017; 2017:7495914. PMID: 29081684; PMCID: PMC5634608.
      Citations: 1     
    57. Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep. 2017 08 25; 7(1):9519. PMID: 28842575; PMCID: PMC5573380.
      Citations: 8     Fields:    Translation:Humans
    58. Stacchiotti S, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Kobayashi E, Casali PG, Provenzano S, Kawai A, Mir O, Le Cesne A, Brahmi M, Blay JY, Italiano A, Duffaud F. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma. Oncologist. 2018 01; 23(1):62-70. PMID: 28754721; PMCID: PMC5759809.
      Citations: 16     Fields:    Translation:Humans
    59. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist. 2017 10; 22(10):1271-1277. PMID: 28710342; PMCID: PMC5634776.
      Citations: 11     Fields:    Translation:Humans
    60. Conley AP, Trinh VA, Zobniw CM, Posey K, Martinez JD, Arrieta OG, Wang WL, Lazar AJ, Somaiah N, Roszik J, Patel SR. Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report. J Glob Oncol. 2018 09; 4:1-6. PMID: 30241159; PMCID: PMC6180844.
      Citations: 13     Fields:    Translation:Humans
    61. Hensley ML, Patel SR, von Mehren M, Ganjoo K, Jones RL, Staddon A, Rushing D, Milhem M, Monk B, Wang G, McCarthy S, Knoblauch RE, Parekh TV, Maki RG, Demetri GD. Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial. Gynecol Oncol. 2017 09; 146(3):531-537. PMID: 28651804; PMCID: PMC5783302.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    62. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal A, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clin Sarcoma Res. 2017; 7:11. PMID: 28630682; PMCID: PMC5471883.
      Citations: 19     
    63. Reddy N, Moudgil R, Lopez-Mattei JC, Karimzad K, Mouhayar EN, Somaiah N, Conley AP, Patel S, Giza DE, Iliescu C. Progressive and Reversible Conduction Disease With Checkpoint Inhibitors. Can J Cardiol. 2017 10; 33(10):1335.e13-1335.e15. PMID: 28822650.
      Citations: 17     Fields:    Translation:Humans
    64. Clarke MJ, Molina CA, Fourney DR, Fisher CG, Gokaslan ZL, Schmidt MH, Rhines LD, Fehlings MG, Laufer I, Patel SR, Rampersaud YR, Reynolds J, Chou D, Bettegowda C, Mendel E, Weber MH, Sciubba DM. Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine. Global Spine J. 2017 Aug; 7(5):460-468. PMID: 28811991; PMCID: PMC5544163.
      Citations: 6     
    65. Ratan R, Patel SR. Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma? Curr Treat Options Oncol. 2017 06; 18(6):34. PMID: 28534249.
      Citations: 7     Fields:    Translation:HumansAnimals
    66. Davis LE, Janeway KA, Weiss AR, Chen YE, Scharschmidt TJ, Krailo M, Glade Bender JL, Kopp LM, Patel SR, Schwartz GK, Horvath LE, Hawkins DS, Chuk MK, Reinke DK, Gorlick RG, Randall RL. Clinical trial enrollment of adolescents and young adults with sarcoma. Cancer. 2017 Sep 15; 123(18):3434-3440. PMID: 28493547; PMCID: PMC5650232.
      Citations: 6     Fields:    Translation:Humans
    67. Shankar GM, Clarke MJ, Ailon T, Rhines LD, Patel SR, Sahgal A, Laufer I, Chou D, Bilsky MH, Sciubba DM, Fehlings MG, Fisher CG, Gokaslan ZL, Shin JH. The role of revision surgery and adjuvant therapy following subtotal resection of osteosarcoma of the spine: a systematic review with meta-analysis. J Neurosurg Spine. 2017 Jul; 27(1):97-104. PMID: 28452631.
      Citations: 10     Fields:    Translation:Humans
    68. Rao P, Matrana MR, Cauley DH, Wood CG, Patel S, Tannir NM, Teegavarapu PS. Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience. Am J Clin Oncol. 2017 Apr; 40(2):189-193. PMID: 25222071; PMCID: PMC4372498.
      Citations: 5     Fields:    Translation:Humans
    69. Patel SR, Lowe S. Accessory Splenic Artery: A Rare Cause of Upper?Gastrointestinal Bleeding. Cardiovasc Intervent Radiol. 2017 Jul; 40(7):1115-1117. PMID: 28154918.
      Citations: 3     Fields:    Translation:Humans
    70. Wang Z, Shi N, Naing A, Janku F, Subbiah V, Araujo DM, Patel SR, Ludwig JA, Ramondetta LM, Levenback CF, Ramirez PT, Piha-Paul SA, Hong D, Karp DD, Tsimberidou AM, Meric-Bernstam F, Fu S. Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience. Cancer Med. 2016 12; 5(12):3437-3444. PMID: 27882721; PMCID: PMC5224847.
      Citations: 10     Fields:    Translation:Humans
    71. Patel SR, Vachhani P, Moeslein F. Embolic Brain?Infarcts: A Rare Fatal Complication of Preoperative Embolization of a Massive Solitary Fibrous Tumor of the Pleura. Cardiovasc Intervent Radiol. 2017 Feb; 40(2):306-309. PMID: 27837239.
      Citations: 2     Fields:    Translation:Humans
    72. Wang J, Varma D, Jensen C, Patnana M, Wei W, Chauhan A, Feig B, Patel S, Somaiah N, Sagebiel T, Bhosale P. Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma? J Comput Assist Tomogr. 2016 Nov/Dec; 40(6):872-879. PMID: 27454788; PMCID: PMC5110394.
      Citations: 6     Fields:    Translation:Humans
    73. Koshkin VS, Bolejack V, Schwartz LH, Wahl RL, Chugh R, Reinke DK, Zhao B, O JH, Patel SR, Schuetze SM, Baker LH. Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival. J Clin Oncol. 2016 Oct 20; 34(30):3680-3685. PMID: 27573658; PMCID: PMC5065114.
      Citations: 8     Fields:    
    74. Subbiah V, Hess KR, Khawaja MR, Wagner MJ, Tang C, Naing A, Fu S, Janku F, Piha-Paul S, Tsimberidou AM, Herzog CE, Ludwig JA, Patel S, Ravi V, Benjamin RS, Meric-Bernstam F, Hong DS. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Sci Rep. 2016 10 17; 6:35448. PMID: 27748430; PMCID: PMC5066200.
      Citations: 7     Fields:    Translation:Humans
    75. Boriani S, Fisher CG, Patel SR, Kawahara N, Mendel E, Bettegowda C, Rhines LD, Charest-Morin R. Benign Tumors of the Spine: Has New Chemotherapy and Interventional Radiology Changed the Treatment Paradigm? Spine (Phila Pa 1976). 2016 Oct 15; 41 Suppl 20:S178-S185. PMID: 27488295.
      Citations: 7     Fields:    Translation:Humans
    76. Goodwin CR, Abu-Bonsrah N, Bilsky MH, Reynolds JJ, Rhines LD, Laufer I, Disch AC, Bozsodi A, Patel SR, Gokaslan ZL, Sciubba DM, Bettegowda C. Clinical Decision Making: Integrating Advances in the Molecular Understanding of Spine Tumors. Spine (Phila Pa 1976). 2016 Oct 15; 41 Suppl 20:S171-S177. PMID: 27488298.
      Citations: 2     Fields:    Translation:Humans
    77. Park H, Garrido-Laguna I, Naing A, Fu S, Falchook GS, Piha-Paul SA, Wheler JJ, Hong DS, Tsimberidou AM, Subbiah V, Zinner RG, Kaseb AO, Patel S, Fanale MA, Velez-Bravo VM, Meric-Bernstam F, Kurzrock R, Janku F. Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. Oncotarget. 2016 Oct 11; 7(41):67521-67531. PMID: 27589687; PMCID: PMC5341894.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    78. Schuetze SM, Bolejack V, Choy E, Ganjoo KN, Staddon AP, Chow WA, Tawbi HA, Samuels BL, Patel SR, von Mehren M, D'Amato G, Leu KM, Loeb DM, Forscher CA, Milhem MM, Rushing DA, Lucas DR, Chugh R, Reinke DK, Baker LH. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer. 2017 Jan 01; 123(1):90-97. PMID: 27696380.
      Citations: 34     Fields:    Translation:HumansCTClinical Trials
    79. Livingston JA, Hess KR, Naing A, Hong DS, Patel S, Benjamin RS, Ludwig JA, Conley A, Herzog CE, Anderson P, Meric-Bernstam F, Kurzrock R, Subbiah V. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. 2016 Sep 27; 7(39):64421-64430. PMID: 27486883; PMCID: PMC5325454.
      Citations: 11     Fields:    Translation:Humans
    80. Batista N, Tee J, Sciubba D, Sahgal A, Laufer I, Weber M, Gokaslan Z, Rhines L, Fehlings M, Patel S, Raja Rampersaud Y, Reynolds J, Chou D, Bettegowda C, Clarke M, Fisher C. Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer: Helping surgeons make decisions. J Clin Neurosci. 2016 Dec; 34:15-22. PMID: 27634496.
      Citations: 10     Fields:    Translation:Humans
    81. Schvartsman G, Wagner MJ, Zobniw CM, Trinh VA, Patel S, Somaiah N. An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients. Curr Oncol Rep. 2016 08; 18(8):49. PMID: 27319943.
      Citations:    Fields:    Translation:Humans
    82. Ratan R, Patel SR. Chemotherapy for soft tissue sarcoma. Cancer. 2016 10; 122(19):2952-60. PMID: 27434055.
      Citations: 63     Fields:    Translation:Humans
    83. Gupta R, Heshami N, Jay C, Ramesh N, Song J, Lei X, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Predictors of survival in patients with sarcoma admitted to the intensive care unit. Clin Sarcoma Res. 2016; 6:12. PMID: 27437097; PMCID: PMC4950117.
      Citations: 2     
    84. Ravi V, Sanford EM, Wang WL, Ross JS, Ramesh N, Futreal A, Patel S, Stephens PJ, Miller VA, Ali SM. Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to Pazopanib. J Natl Compr Canc Netw. 2016 05; 14(5):499-502. PMID: 27160228.
      Citations: 13     Fields:    Translation:HumansCells
    85. Wagner MJ, Livingston JA, Patel SR, Benjamin RS. Chemotherapy for Bone Sarcoma in Adults. J Oncol Pract. 2016 Mar; 12(3):208-16. PMID: 26962160.
      Citations: 15     Fields:    Translation:Humans
    86. Chawla S, Maki RG, Gelderblom H, Choy E, Grignani G, Bauer S, Rha SY, Hohenberger P, D'Adamo D, Guo M, Chmielowski B, Le Cesne A, Demetri GD, Patel SR, Sch?ffski P, Italiano A, Camargo V, Blay JY. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet. 2016 Apr 16; 387(10028):1629-37. PMID: 26874885.
      Citations: 224     Fields:    Translation:HumansCTClinical Trials
    87. Schuetze SM, Wathen JK, Lucas DR, Choy E, Samuels BL, Staddon AP, Ganjoo KN, von Mehren M, Chow WA, Loeb DM, Tawbi HA, Rushing DA, Patel SR, Thomas DG, Chugh R, Reinke DK, Baker LH. SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma. Cancer. 2016 Mar 15; 122(6):868-74. PMID: 26710211.
      Citations: 38     Fields:    Translation:HumansCTClinical Trials
    88. Etchebehere EC, Hobbs BP, Malawi O, Patel S, Benjamin RS, Macapinlac HA, Milton DR. Assessing the role of ?8F-FDG PET and ?8F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2016 May; 43(5):860-870. PMID: 26631240; PMCID: PMC5048410.
      Citations: 9     Fields:    Translation:Humans
    89. Joseph J, Wang WL, Ramesh N, Benjamin R, Patel S, Ravi V, Patnana M. Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma. Clin Sarcoma Res. 2015; 5:22. PMID: 26500758; PMCID: PMC4615364.
      Citations: 11     
    90. Demetri GD, von Mehren M, Jones RL, Hensley ML, Schuetze SM, Staddon A, Milhem M, Elias A, Ganjoo K, Tawbi H, Van Tine BA, Spira A, Dean A, Khokhar NZ, Park YC, Knoblauch RE, Parekh TV, Maki RG, Patel SR. Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. J Clin Oncol. 2016 Mar 10; 34(8):786-93. PMID: 26371143; PMCID: PMC5070559.
      Citations: 230     Fields:    Translation:HumansCTClinical Trials
    91. Fan Z, Patel S, Lewis VO, Guadagnolo BA, Lin PP. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas? Clin Orthop Relat Res. 2015 Nov; 473(11):3604-11. PMID: 26197952; PMCID: PMC4586239.
      Citations: 15     Fields:    Translation:Humans
    92. Tseng WW, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PW. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67. PMID: 26177983; PMCID: PMC4777348.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    93. Subbiah V, McMahon C, Patel S, Zinner R, Silva EG, Elvin JA, Subbiah IM, Ohaji C, Ganeshan DM, Anand D, Levenback CF, Berry J, Brennan T, Chmielecki J, Chalmers ZR, Mayfield J, Miller VA, Stephens PJ, Ross JS, Ali SM. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion. J Hematol Oncol. 2015 Jun 11; 8:66. PMID: 26062823; PMCID: PMC4467062.
      Citations: 29     Fields:    Translation:Humans
    94. Goldschlager T, Dea N, Boyd M, Reynolds J, Patel S, Rhines LD, Mendel E, Pacheco M, Ramos E, Mattei TA, Fisher CG. Giant cell tumors of the spine: has denosumab changed the treatment paradigm? J Neurosurg Spine. 2015 May; 22(5):526-33. PMID: 25700239.
      Citations: 28     Fields:    Translation:Humans
    95. Ravi V, Patel S, Benjamin RS. Chemotherapy for soft-tissue sarcomas. Oncology (Williston Park). 2015 Jan; 29(1):43-50. PMID: 25592207.
      Citations: 9     Fields:    Translation:Humans
    96. Benjamin RS, Wagner MJ, Livingston JA, Ravi V, Patel SR. Chemotherapy for bone sarcomas in adults: the MD anderson experience. Am Soc Clin Oncol Educ Book. 2015; e656-60. PMID: 25993237.
      Citations: 5     Fields:    Translation:Humans
    97. Bellera CA, Penel N, Ouali M, Bonvalot S, Casali PG, Nielsen OS, Benjamin RS, Delaney TF, Duffaud F, Filleron T, Fiore M, Gelderblom H, George S, Grimer R, Grosclaude P, Gronchi A, Haas R, Hohenberger P, Issels R, Jooste V, Krarup-Hansen A, Mussi C, Oberlin O, Patel S, Piperno-Neumann S, Raut C, Rutkowski P, Schuetze S, Sleijfer S, Van Glabbeke M, Woll P, Gourgou-Bourgade S, Delannes M, Liti?re S, Bonnetain F, Dabakuyo TS, Blay JY, Bui BN, Collin F, Italiano A, Le P?choux C, Ray-Coquard I, Stoeckle E, Mathoulin-P?lissier S. Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)?. Ann Oncol. 2015 May; 26(5):865-872. PMID: 25070543.
      Citations: 15     Fields:    Translation:Humans
    98. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL, Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma. 2014; 2014:375151. PMID: 25024639; PMCID: PMC4082947.
      Citations: 15     
    99. Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, Arfi-Roufe J, Berdelou A, Moon B, Al Ghuzlan A, Patel S, Leboulleux S, Jimenez C. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. Eur J Endocrinol. 2014 Sep; 171(3):R111-22. PMID: 24891137.
      Citations: 42     Fields:    Translation:HumansAnimals
    100. Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, Weigel B, Randall L, Withrow SJ, Paoloni M, Kaplan R, Teicher BA, Seibel NL, Smith M, Uren A, Patel SR, Trent J, Savage SA, Mirabello L, Reinke D, Barkaukas DA, Krailo M, Bernstein M. Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res. 2014 Aug 15; 20(16):4200-9. PMID: 24803583; PMCID: PMC4134738.
      Citations: 74     Fields:    Translation:HumansAnimals
    101. Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PW, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014 May 20; 32(15):1563-70. PMID: 24638003; PMCID: PMC4026579.
      Citations: 94     Fields:    Translation:Humans
    102. Leahy MG, Nguyen BB, Patel SR, Santoro A, Staddon AP, Penel N, Piperno-Neumann S, Hendifar A, Lardelli P, Nieto A, Alfaro V, Chawla SP, Blay JY, Hohenberger P. Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas. Eur J Cancer. 2014 Apr; 50(6):1137-47. PMID: 24512981.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    103. Patel SR. Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy. Am Soc Clin Oncol Educ Book. 2014; 259-62. PMID: 24857084.
      Citations: 3     Fields:    Translation:HumansAnimals
    104. Ganjoo KN, Patel S. The treatment outcome for adult patients with Ewing's sarcoma. Curr Oncol Rep. 2013 Aug; 15(4):372-7. PMID: 23605781.
      Citations: 4     Fields:    Translation:Humans
    105. Ravi V, Patel S. Vascular sarcomas. Curr Oncol Rep. 2013 Aug; 15(4):347-55. PMID: 23852636.
      Citations: 18     Fields:    Translation:Humans
    106. Patel S. Exploring novel therapeutic targets in GIST: focus on the PI3K/Akt/mTOR pathway. Curr Oncol Rep. 2013 Aug; 15(4):386-95. PMID: 23605780.
      Citations: 31     Fields:    Translation:Humans
    107. Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med. 2013 Aug; 2(4):553-63. PMID: 24156028; PMCID: PMC3799290.
      Citations: 14     Fields:    Translation:Humans
    108. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res. 2013 May 11; 3(1):7. PMID: 23663788; PMCID: PMC3660184.
      Citations: 28     
    109. Yadav BS, Bansal A, Sharma SC, Javid SH, Anderson BO, Vaklavas C, Forero A, Ravi V, Patel S, Boudadi K, Chugh R, Morris GJ. A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer. Semin Oncol. 2013 Apr; 40(2):135-44. PMID: 23540738.
      Citations: 3     Fields:    Translation:Humans
    110. Patel S. Long-term efficacy of imatinib for treatment of metastatic GIST. Cancer Chemother Pharmacol. 2013 Aug; 72(2):277-86. PMID: 23503753.
      Citations: 14     Fields:    Translation:Humans
    111. Samuels BL, Chawla S, Patel S, von Mehren M, Hamm J, Kaiser PE, Schuetze S, Li J, Aymes A, Demetri GD. Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study. Ann Oncol. 2013 Jun; 24(6):1703-9. PMID: 23385197.
      Citations: 47     Fields:    Translation:HumansCTClinical Trials
    112. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ, L?pez-Terrada D. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res. 2012 Dec 29; 2(1):25. PMID: 23272660; PMCID: PMC3599544.
      Citations: 5     
    113. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S. Prognostic significance of elevated D-dimer for survival in patients with sarcoma. Am J Clin Oncol. 2012 Oct; 35(5):462-7. PMID: 21654313.
      Citations: 9     Fields:    Translation:HumansCells
    114. Richey SL, Rao P, Wood CG, Patel S, Tannir NM. Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy. Clin Genitourin Cancer. 2012 Sep; 10(3):210-2. PMID: 22503609; PMCID: PMC4121061.
      Citations: 4     Fields:    Translation:Humans
    115. Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ. Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. Oncologist. 2012; 17(3):321. PMID: 22363068; PMCID: PMC3316916.
      Citations: 35     Fields:    Translation:HumansCTClinical Trials
    116. Ravi V, Patel S. Adjuvant chemotherapy for soft tissue sarcomas. Surg Oncol Clin N Am. 2012 Apr; 21(2):243-53. PMID: 22365517.
      Citations:    Fields:    Translation:Humans
    117. Chen LL, Chen X, Choi H, Sang H, Chen LC, Zhang H, Gouw L, Andtbacka RH, Chan BK, Rodesch CK, Jimenez A, Cano P, Jones KA, Oyedeji CO, Martins T, Hill HR, Schumacher J, Willmore C, Scaife CL, Ward JH, Morton K, Randall RL, Lazar AJ, Patel S, Trent JC, Frazier ML, Lin P, Jensen P, Benjamin RS. Exploiting antitumor immunity to overcome relapse and improve remission duration. Cancer Immunol Immunother. 2012 Jul; 61(7):1113-24. PMID: 22198309; PMCID: PMC3378844.
      Citations: 20     Fields:    Translation:HumansCellsCTClinical Trials
    118. Patel S. Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance. Cancer Treat Rev. 2012 Aug; 38(5):467-72. PMID: 22035971.
      Citations: 6     Fields:    Translation:Humans
    119. Patel SR, Crowley J, Reinke DK, Kuenkele KP, Chawla SP, Toner GC, Maki RG, Meyers PA, Chugh R, Ganjoo KN, Schuetze SM, Juergens H, Leahy MG, Geoerger B, Benjamin RS, Helman LJ, Baker LH, Pappo AS. R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study. J Clin Oncol. 2011 Dec 01; 29(34):4541-7. PMID: 22025149; PMCID: PMC3236654.
      Citations: 155     Fields:    Translation:HumansCTClinical Trials
    120. Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 01; 118(11):2804-12. PMID: 22006217; PMCID: PMC3882190.
      Citations: 43     Fields:    Translation:Humans
    121. Fourney DR, Frangou EM, Ryken TC, Dipaola CP, Shaffrey CI, Berven SH, Bilsky MH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fisher CG. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol. 2011 Aug 01; 29(22):3072-7. PMID: 21709187.
      Citations: 138     Fields:    Translation:Humans
    122. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer. 2011 Nov 01; 117(21):4939-47. PMID: 21480200; PMCID: PMC3135685.
      Citations: 72     Fields:    Translation:Humans
    123. Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL. Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer. 2011 Dec 15; 57(7):1142-6. PMID: 21394894; PMCID: PMC3134599.
      Citations: 17     Fields:    Translation:Humans
    124. Clark DW, Moore BA, Patel SR, Guadagnolo BA, Roberts DB, Sturgis EM. Malignant fibrous histiocytoma of the head and neck region. Head Neck. 2011 Mar; 33(3):303-8. PMID: 20629084.
      Citations: 2     Fields:    Translation:Humans
    125. Ganjoo KN, Patel S. Current and emerging pharmacological treatments for gastrointestinal stromal tumour. Drugs. 2011 Feb 12; 71(3):321-30. PMID: 21319869.
      Citations: 3     Fields:    Translation:Humans
    126. Patel S. Navigating risk stratification systems for the management of patients with GIST. Ann Surg Oncol. 2011 Jun; 18(6):1698-704. PMID: 21213058.
      Citations: 14     Fields:    Translation:Humans
    127. Huh WW, Guadagnolo BA, Munsell MF, Patel S, Lewis VO. Soft tissue sarcomas of the popliteal fossa: a single-institution retrospective review. Cancer. 2011 Jun 15; 117(12):2728-34. PMID: 21656751.
      Citations:    Fields:    Translation:Humans
    128. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25. PMID: 21190975.
      Citations: 138     Fields:    Translation:Humans
    129. Patel SR. Gastrointestinal Stromal Tumors (GIST) special issue. Preface. Cancer Chemother Pharmacol. 2011 Jan; 67 Suppl 1:S1. PMID: 21116629.
      Citations:    Fields:    Translation:Humans
    130. Fisher CG, DiPaola CP, Ryken TC, Bilsky MH, Shaffrey CI, Berven SH, Harrop JS, Fehlings MG, Boriani S, Chou D, Schmidt MH, Polly DW, Biagini R, Burch S, Dekutoski MB, Ganju A, Gerszten PC, Gokaslan ZL, Groff MW, Liebsch NJ, Mendel E, Okuno SH, Patel S, Rhines LD, Rose PS, Sciubba DM, Sundaresan N, Tomita K, Varga PP, Vialle LR, Vrionis FD, Yamada Y, Fourney DR. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010 Oct 15; 35(22):E1221-9. PMID: 20562730.
      Citations: 236     Fields:    Translation:Humans
    131. Pisters PW, Patel SR. Gastrointestinal stromal tumors: current management. J Surg Oncol. 2010 Oct 01; 102(5):530-8. PMID: 20063363.
      Citations: 15     Fields:    Translation:Humans
    132. Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS. Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial. Ann Intern Med. 2010 Sep 21; 153(6):358-67. PMID: 20855800.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    133. Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, Benjamin RS, Baker LH, Sarcoma Alliance for Research through Collaboration (SARC). Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res. 2010 Oct 01; 16(19):4884-91. PMID: 20724445.
      Citations: 71     Fields:    Translation:HumansCTClinical Trials
    134. Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K, Renard M, Sciot R, Rao P, Oberlin O, Delattre O, Shipley J. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer. 2010 Jun 08; 102(12):1769-77. PMID: 20502458; PMCID: PMC2883695.
      Citations: 57     Fields:    Translation:HumansCells
    135. Pandurengan RK, Dumont AG, Araujo DM, Ludwig JA, Ravi V, Patel S, Garber J, Benjamin RS, Strom SS, Trent JC. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol. 2010 Oct; 21(10):2107-2111. PMID: 20348145; PMCID: PMC2946863.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    136. Trent JC, Patel SS, Zhang J, Araujo DM, Plana JC, Lenihan DJ, Fan D, Patel SR, Benjamin RS, Khakoo AY. Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate. Cancer. 2010 Jan 01; 116(1):184-92. PMID: 19885836; PMCID: PMC4306337.
      Citations: 22     Fields:    Translation:HumansCells
    137. Ganjoo KN, Demetri GD, Jacobs C, Patel S. Acute myeloid leukemia in patients with gastrointestinal stromal tumors treated with Gleevec. Leuk Lymphoma. 2009 Nov; 50(11):1882-4. PMID: 19883316.
      Citations: 2     Fields:    Translation:Humans
    138. Ganjoo KN, Patel SR. Trabectedin: an anticancer drug from the sea. Expert Opin Pharmacother. 2009 Nov; 10(16):2735-43. PMID: 19743937.
      Citations: 7     Fields:    Translation:Humans
    139. Yamazaki T, McLoughlin GS, Patel S, Rhines LD, Fourney DR. Feasibility and safety of en bloc resection for primary spine tumors: a systematic review by the Spine Oncology Study Group. Spine (Phila Pa 1976). 2009 Oct 15; 34(22 Suppl):S31-8. PMID: 19829275.
      Citations: 29     Fields:    Translation:Humans
    140. Schuetze SM, Patel S. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy? Oncologist. 2009 Oct; 14(10):1003-12. PMID: 19808770.
      Citations: 17     Fields:    Translation:Humans
    141. Gupta GR, Yasko AW, Lewis VO, Cannon CP, Raymond AK, Patel S, Lin PP. Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer. 2009 Aug 15; 115(16):3767-73. PMID: 19517468.
      Citations: 8     Fields:    Translation:Humans
    142. Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, del Muro XG. Sarcomas with spindle cell morphology. Semin Oncol. 2009 Aug; 36(4):324-37. PMID: 19664493.
      Citations: 9     Fields:    Translation:Humans
    143. Chugh R, Wathen JK, Maki RG, Benjamin RS, Patel SR, Meyers PA, Myers PA, Priebat DA, Reinke DK, Thomas DG, Keohan ML, Samuels BL, Baker LH. Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model. J Clin Oncol. 2009 Jul 01; 27(19):3148-53. PMID: 19451433.
      Citations: 83     Fields:    Translation:HumansCTClinical Trials
    144. Rolston KV, Frisbee-Hume SE, Patel S, Manzullo EF, Benjamin RS. Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients. Support Care Cancer. 2010 Jan; 18(1):89-94. PMID: 19387695.
      Citations: 9     Fields:    Translation:Humans
    145. Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K, American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009 Mar 28; 373(9669):1097-104. PMID: 19303137; PMCID: PMC2915459.
      Citations: 455     Fields:    Translation:HumansCTClinical Trials
    146. Trent JC, Patel SR. Clinical update on adult and pediatric gastrointestinal stromal tumor. Preface. Hematol Oncol Clin North Am. 2009 Feb; 23(1):xiii-xiv. PMID: 19248966.
      Citations:    Fields:    Translation:Humans
    147. Benjamin RS, Patel SR. Pediatric and adult osteosarcoma: comparisons and contrasts in presentation and therapy. Cancer Treat Res. 2009; 152:355-63. PMID: 20213401.
      Citations: 6     Fields:    Translation:Humans
    148. Davis EC, Ballo MT, Luna MA, Patel SR, Roberts DB, Nong X, Sturgis EM. Liposarcoma of the head and neck: The University of Texas M. D. Anderson Cancer Center experience. Head Neck. 2009 Jan; 31(1):28-36. PMID: 18767171.
      Citations: 15     Fields:    Translation:Humans
    149. Rao G, Suki D, Chakrabarti I, Feiz-Erfan I, Mody MG, McCutcheon IE, Gokaslan Z, Patel S, Rhines LD. Surgical management of primary and metastatic sarcoma of the mobile spine. J Neurosurg Spine. 2008 Aug; 9(2):120-8. PMID: 18764743.
      Citations: 21     Fields:    Translation:Humans
    150. Patel S, Zalcberg JR. Optimizing the dose of imatinib for treatment of gastrointestinal stromal tumours: lessons from the phase 3 trials. Eur J Cancer. 2008 Mar; 44(4):501-9. PMID: 18234488.
      Citations: 16     Fields:    Translation:Humans
    151. Kopp HG, Patel S, Br?cher B, Hartmann JT. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma. Am J Clin Dermatol. 2008; 9(4):207-17. PMID: 18572972.
      Citations: 8     Fields:    Translation:Humans
    152. Armistead PM, Salganick J, Roh JS, Steinert DM, Patel S, Munsell M, El-Naggar AK, Benjamin RS, Zhang W, Trent JC. Expression of receptor tyrosine kinases and apoptotic molecules in rhabdomyosarcoma: correlation with overall survival in 105 patients. Cancer. 2007 Nov 15; 110(10):2293-303. PMID: 17896786.
      Citations: 30     Fields:    Translation:Humans
    153. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Benjamin RS, Pollock RE. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Mar 01; 70(3):760-5. PMID: 17892916.
      Citations: 33     Fields:    Translation:Humans
    154. Guadagnolo BA, Zagars GK, Ballo MT, Patel SR, Lewis VO, Pisters PW, Benjamin RS, Pollock RE. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1173-80. PMID: 17689031.
      Citations: 22     Fields:    Translation:Humans
    155. Harb WJ, Luna MA, Patel SR, Ballo MT, Roberts DB, Sturgis EM. Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension. Head Neck. 2007 Aug; 29(8):731-40. PMID: 17274049.
      Citations: 40     Fields:    Translation:Humans
    156. Maki RG, Wathen JK, Patel SR, Priebat DA, Okuno SH, Samuels B, Fanucchi M, Harmon DC, Schuetze SM, Reinke D, Thall PF, Benjamin RS, Baker LH, Hensley ML. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. J Clin Oncol. 2007 Jul 01; 25(19):2755-63. PMID: 17602081.
      Citations: 228     Fields:    Translation:HumansCTClinical Trials
    157. Benjamin RS, Choi H, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Charnsangavej C. We should desist using RECIST, at least in GIST. J Clin Oncol. 2007 May 01; 25(13):1760-4. PMID: 17470866.
      Citations: 190     Fields:    Translation:Humans
    158. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, Lazar AA, Patel SR, Benjamin RS, Pollock RE. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007 May 01; 25(13):1785-91. PMID: 17470870.
      Citations: 84     Fields:    Translation:Humans
    159. Choi H, Charnsangavej C, Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol. 2007 May 01; 25(13):1753-9. PMID: 17470865.
      Citations: 480     Fields:    Translation:Humans
    160. Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, Patel SR, Madewell JE, Lewis VO, Cannon CP, Benjamin RS, Yasko AW. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer. 2007 Feb 01; 109(3):603-11. PMID: 17177205.
      Citations: 28     Fields:    Translation:Humans
    161. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007 Jan; 14(1):14-24. PMID: 17072676.
      Citations: 90     Fields:    Translation:Humans
    162. Patel S, Keohan ML, Saif MW, Rushing D, Baez L, Feit K, DeJager R, Anderson S. Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy. Cancer. 2006 Dec 15; 107(12):2881-7. PMID: 17109446.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    163. Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63. PMID: 17084545.
      Citations: 35     Fields:    Translation:Humans
    164. Chirieac LR, Trent JC, Steinert DM, Choi H, Yang Y, Zhang J, Patel SR, Benjamin RS, Raymond AK. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Cancer. 2006 Nov 01; 107(9):2237-44. PMID: 16998931.
      Citations: 7     Fields:    Translation:Humans
    165. Rolston KV, Manzullo EF, Elting LS, Frisbee-Hume SE, McMahon L, Theriault RL, Patel S, Benjamin RS. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules. Cancer. 2006 Jun 01; 106(11):2489-94. PMID: 16628654.
      Citations: 9     Fields:    Translation:Humans
    166. Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, Burgess M, Patel S, Pollock RE, Cormier JN. Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8. PMID: 16288486.
      Citations: 54     Fields:    Translation:Humans
    167. Patel SR, Benjamin RS. Desmoid tumors respond to chemotherapy: defying the dogma in oncology. J Clin Oncol. 2006 Jan 01; 24(1):11-2. PMID: 16330666.
      Citations: 22     Fields:    Translation:Humans
    168. Chen LL, Sabripour M, Andtbacka RH, Patel SR, Feig BW, Macapinlac HA, Choi H, Wu EF, Frazier ML, Benjamin RS. Imatinib resistance in gastrointestinal stromal tumors. Curr Oncol Rep. 2005 Jul; 7(4):293-9. PMID: 15946589.
      Citations: 8     Fields:    Translation:Humans
    169. Patel S, Hartmann JT. New drug developments for patients with metastatic soft tissue sarcoma. Curr Oncol Rep. 2005 Jul; 7(4):300-6. PMID: 15946590.
      Citations: 3     Fields:    Translation:Humans
    170. Steinert DM, Patel SR. Recent studies in novel therapy for metastatic sarcomas. Hematol Oncol Clin North Am. 2005 Jun; 19(3):573-90, viii. PMID: 15939198.
      Citations: 3     Fields:    Translation:Humans
    171. Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005 Sep; 20(9):1562-8. PMID: 16059628.
      Citations: 7     Fields:    Translation:Humans
    172. Patel S, Hartmann JT. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma. Drugs. 2005; 65(2):167-78. PMID: 15631540.
      Citations: 13     Fields:    Translation:HumansAnimals
    173. Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 01; 64(17):5913-9. PMID: 15342366.
      Citations: 98     Fields:    Translation:HumansCells
    174. Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80. PMID: 15310783.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    175. Patel SR, Papadopolous N, Raymond AK, Donato M, Seong CM, Yasko AW, Lewis VO, Lin PP, Champlin R, Benjamin RS. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis. Cancer. 2004 Jul 01; 101(1):156-63. PMID: 15222001.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    176. Patel SR. Classification of clear-cell sarcoma. Curr Oncol Rep. 2004 Jul; 6(4):307. PMID: 15161585.
      Citations:    Fields:    
    177. Patel SR. Molecular testing for synovial sarcoma. Curr Oncol Rep. 2004 Jul; 6(4):308. PMID: 15161586.
      Citations:    Fields:    
    178. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PW. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7. PMID: 15050324.
      Citations: 17     Fields:    Translation:Humans
    179. Trent JC, Beach J, Burgess MA, Papadopolous N, Chen LL, Benjamin RS, Patel SR. A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas. Cancer. 2003 Dec 15; 98(12):2693-9. PMID: 14669291.
      Citations: 33     Fields:    Translation:HumansCTClinical Trials
    180. Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW. Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg. 2003 Dec; 186(6):665-9. PMID: 14672776.
      Citations: 34     Fields:    Translation:Humans
    181. Phan A, Patel S. Advances in neoadjuvant chemotherapy in soft tissue sarcomas. Curr Treat Options Oncol. 2003 Dec; 4(6):433-9. PMID: 14585224.
      Citations: 3     Fields:    Translation:Humans
    182. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):739-47. PMID: 14529779.
      Citations: 36     Fields:    Translation:Humans
    183. Vadhan-Raj S, Patel S, Bueso-Ramos C, Folloder J, Papadopolous N, Burgess A, Broemeling LD, Broxmeyer HE, Benjamin RS. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia. J Clin Oncol. 2003 Aug 15; 21(16):3158-67. PMID: 12915607.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    184. Pisters PW, Ballo MT, Fenstermacher MJ, Feig BW, Hunt KK, Raymond KA, Burgess MA, Zagars GK, Pollock RE, Benjamin RS, Patel SR. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7. PMID: 12915599.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    185. Trent JC, Valero V, Booser DJ, Esparza-Guerra LT, Ibrahim N, Rahman Z, Vernillet L, Patel S, David CL, Murray JL, Cristofanilli M, Hortobagyi GN. A Phase I study of docetaxel plus cyclophosphamide in solid tumors followed by a Phase II study as first-line therapy in metastatic breast cancer. Clin Cancer Res. 2003 Jul; 9(7):2426-34. PMID: 12855614.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    186. Patel SR. Early results from randomized phase III trial of imatinib mesylate for gastrointestinal stromal tumors. Curr Oncol Rep. 2003 Jul; 5(4):273. PMID: 12781067.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    187. Patel SR, Beach J, Papadopoulos N, Burgess MA, Trent J, Jenkins J, Benjamin RS. Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas. Cancer. 2003 Jun 01; 97(11):2848-52. PMID: 12767099.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    188. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):482-8. PMID: 12738324.
      Citations: 37     Fields:    Translation:Humans
    189. Patel SR, Zagars GK, Pisters PW. The follow-up of adult soft-tissue sarcomas. Semin Oncol. 2003 Jun; 30(3):413-6. PMID: 12870143.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    190. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy. Cancer. 2003 May 15; 97(10):2544-53. PMID: 12733154.
      Citations: 48     Fields:    Translation:Humans
    191. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003 May 15; 97(10):2530-43. PMID: 12733153.
      Citations: 203     Fields:    Translation:Humans
    192. Patel SR. Recent advances in systemic therapy of soft tissue sarcomas. Expert Rev Anticancer Ther. 2003 Apr; 3(2):179-84. PMID: 12722877.
      Citations: 1     Fields:    Translation:Humans
    193. Meric F, Hess KR, Varma DG, Hunt KK, Pisters PW, Milas KM, Patel SR, Benjamin RS, Plager C, Papadopoulos NE, Burgess MA, Pollock RE, Feig BW. Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer. 2002 Sep 01; 95(5):1120-6. PMID: 12209699.
      Citations: 26     Fields:    Translation:Humans
    194. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS, Benjamin RS. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002 Jul 15; 95(2):377-88. PMID: 12124838.
      Citations: 72     Fields:    Translation:Humans
    195. Pisters PW, Ballo MT, Patel SR. Preoperative chemoradiation treatment strategies for localized sarcoma. Ann Surg Oncol. 2002 Jul; 9(6):535-42. PMID: 12095968.
      Citations: 14     Fields:    Translation:Humans
    196. Bilimoria MM, Holtz DJ, Mirza NQ, Feig BW, Pisters PW, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KK. Tumor volume as a prognostic factor for sarcomatosis. Cancer. 2002 May 01; 94(9):2441-6. PMID: 12015769.
      Citations: 17     Fields:    Translation:Humans
    197. Ahmad SA, Patel SR, Ballo MT, Baker TP, Yasko AW, Wang X, Feig BW, Hunt KK, Lin PP, Weber KL, Chen LL, Zagars GK, Pollock RE, Benjamin RS, Pisters PW. Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002 Jan 15; 20(2):521-7. PMID: 11786582.
      Citations: 44     Fields:    Translation:Humans
    198. Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer. 2002 Jan 01; 94(1):197-204. PMID: 11815977.
      Citations: 9     Fields:    Translation:Humans
    199. Callister MD, Ballo MT, Pisters PW, Patel SR, Feig BW, Pollock RE, Benjamin RS, Zagars GK. Epithelioid sarcoma: results of conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):384-91. PMID: 11567812.
      Citations: 29     Fields:    Translation:HumansPHPublic Health
    200. Ballo MT, Zagars GK, Pisters PW, Feig BW, Patel SR, von Eschenbach AC. Spermatic cord sarcoma: outcome, patterns of failure and management. J Urol. 2001 Oct; 166(4):1306-10. PMID: 11547063.
      Citations: 45     Fields:    Translation:Humans
    201. Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PW. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5. PMID: 11745234.
      Citations: 9     Fields:    Translation:Humans
    202. Socinski MA, Rosenman JG, Halle J, Schell MJ, Lin Y, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial. Cancer. 2001 Sep 01; 92(5):1213-23. PMID: 11571735.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    203. Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, Patel SR, Benjamin RS, Pollock RE, Pisters PW. Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer. 2001 Aug 15; 92(4):863-8. PMID: 11550159.
      Citations: 12     Fields:    Translation:Humans
    204. Patel SR, Gandhi V, Jenkins J, Papadopolous N, Burgess MA, Plager C, Plunkett W, Benjamin RS. Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. J Clin Oncol. 2001 Aug 01; 19(15):3483-9. PMID: 11481354.
      Citations: 66     Fields:    Translation:HumansCellsCTClinical Trials
    205. Portera CA, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, Yasko AW, Benjamin RS, Pollock RE, Pisters PW. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001 Feb 01; 91(3):585-91. PMID: 11169942.
      Citations: 102     Fields:    Translation:Humans
    206. Eisenburg BL, Alektiar K, Ballo M, DeLaney TF, Ettinger D, Harmon D, Harris J, Joyce M, Kraybill WG, Leider S, Lucas D, Peterson I, Pollock RE, Pritchard D, Schwartz HS, Yasko AW, Pisters PT, Patel SR, watson J, Radiation Therapy Oncology Group. Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):53-5. PMID: 11641015.
      Citations:    Fields:    Translation:Humans
    207. Meric F, Milas M, Hunt KK, Hess KR, Pisters PW, Hildebrandt G, Patel SR, Benjamin RS, Plager C, Papadopolous NE, Burgess MA, Pollock RE, Feig BW. Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol. 2000 Oct 01; 18(19):3378-83. PMID: 11013278.
      Citations: 15     Fields:    Translation:Humans
    208. Patel SR. Radiation-induced sarcoma. Curr Treat Options Oncol. 2000 Aug; 1(3):258-61. PMID: 12057168.
      Citations: 30     Fields:    Translation:Humans
    209. Patel SR, Benjamin RS. Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors. Surg Oncol. 2000 Aug; 9(2):67-70. PMID: 11094325.
      Citations: 6     Fields:    Translation:Humans
    210. Patel SR. New agents in the treatment of soft-tissue sarcomas. Expert Opin Investig Drugs. 2000 Jul; 9(7):1545-51. PMID: 11060759.
      Citations: 3     Fields:    Translation:HumansAnimals
    211. Valenzuela RF, Kim EE, Seo JG, Patel S, Yasko AW. A revisit of MRI analysis for synovial sarcoma. Clin Imaging. 2000 Jul-Aug; 24(4):231-5. PMID: 11274890.
      Citations: 12     Fields:    Translation:Humans
    212. Spillane A, Thomas JM, Pisters PW, Pollock RE, Patel SR, Benjamin RS. Misconceptions with staging of soft tissue sarcoma. J Clin Oncol. 2000 Apr; 18(8):1800-1. PMID: 10764441.
      Citations:    Fields:    Translation:Humans
    213. Fleming JB, Berman RS, Cheng SC, Chen NP, Hunt KK, Feig BW, Respondek PM, Yasko AW, Pollack A, Patel SR, Burgess MA, Papadopoulos NE, Plager C, Zagars G, Benjamin RS, Pollock RE, Pisters PW. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80. PMID: 10561352.
      Citations: 11     Fields:    Translation:Humans
    214. Patel SR, Benjamin RS. New chemotherapeutic strategies for soft tissue sarcomas. Semin Surg Oncol. 1999 Jul-Aug; 17(1):47-51. PMID: 10402637.
      Citations: 5     Fields:    Translation:Humans
    215. Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999 Jan 01; 85(1):85-92. PMID: 9921978.
      Citations: 33     Fields:    Translation:Humans
    216. Patel SR, Vadhan-Raj S, Burgess MA, Plager C, Papadopolous N, Jenkins J, Benjamin RS. Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas. Am J Clin Oncol. 1998 Jun; 21(3):317-21. PMID: 9626808.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    217. Patel SR, Burgess MA, Papadopolous NE, Sidhu G, Gray R, Plager C, Jenkins J, Benjamin RS. Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas. Invest New Drugs. 1998; 16(1):87-92. PMID: 9740549.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    218. Pisters PW, Patel SR, Varma DG, Cheng SC, Chen NP, Nguyen HT, Feig BW, Pollack A, Pollock RE, Benjamin RS. Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution. J Clin Oncol. 1997 Dec; 15(12):3481-7. PMID: 9396401.
      Citations: 24     Fields:    Translation:Humans
    219. Worth LL, Jaffe N, Benjamin RS, Papadopoulos NE, Patel S, Raymond AK, Jia SF, Rodriguez C, Gano J, Gianan MA, Kleinerman ES. Phase II study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Clin Cancer Res. 1997 Oct; 3(10):1721-9. PMID: 9815556.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    220. Patel SR, Vadhan-Raj S, Papadopolous N, Plager C, Burgess MA, Hays C, Benjamin RS. High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence. J Clin Oncol. 1997 Jun; 15(6):2378-84. PMID: 9196153.
      Citations: 44     Fields:    Translation:HumansCTClinical Trials
    221. Vadhan-Raj S, Murray LJ, Bueso-Ramos C, Patel S, Reddy SP, Hoots WK, Johnston T, Papadopolous NE, Hittelman WN, Johnston DA, Yang TA, Paton VE, Cohen RL, Hellmann SD, Benjamin RS, Broxmeyer HE. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med. 1997 May 01; 126(9):673-81. PMID: 9139552.
      Citations: 30     Fields:    Translation:HumansCellsCTClinical Trials
    222. Patel SR, Linke KA, Burgess MA, Papadopoulos NE, Plager C, Jenkins J, Benjamin R. Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas. Sarcoma. 1997; 1(2):95-7. PMID: 18521208; PMCID: PMC2395357.
      Citations: 4     
    223. Roth JA, Beech DJ, Putnam JB, Pollock RE, Patel SR, Fidler IJ, Benjamin RS. Treatment of the patient with lung metastases. Curr Probl Surg. 1996 Nov; 33(11):881-952. PMID: 8909328.
      Citations: 1     Fields:    Translation:HumansAnimals
    224. Claxton D, Xie QS, Patel S, Deisseroth AB, Kornblau S. The gene product of CBFB-MYH11. Leukemia. 1996 Sep; 10(9):1479-85. PMID: 8751466.
      Citations: 1     Fields:    Translation:HumansCells
    225. Patel SR, Papadopoulos NE, Plager C, Linke KA, Moseley SH, Spirindonidis CH, Benjamin R. Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants. Cancer. 1996 Aug 15; 78(4):741-4. PMID: 8756366.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    226. Patel SR, Benjamin RS. Ifosfamide in sarcomas: is it a schedule-dependent drug? Cancer Invest. 1996; 14(3):290-1. PMID: 8630693.
      Citations:    Fields:    Translation:Humans
    227. Patel SR, Plager C, Papadopoulos NE, Benjamin RS. Myxoid malignant fibrous histiocytoma: experience with chemotherapy. Am J Clin Oncol. 1995 Dec; 18(6):528-31. PMID: 8526198.
      Citations: 2     Fields:    Translation:Humans
    228. Patel SR, Winchester DJ, Benjamin RS. A 15-year experience with chemotherapy of patients with paraganglioma. Cancer. 1995 Oct 15; 76(8):1476-80. PMID: 8620426.
      Citations: 23     Fields:    Translation:Humans
    229. Drach J, Kornblau SM, Patel S, Novaes M, Khetan R, Sawaya N, Dorlhiac-Llacer P, Chamone DF, Andreeff M, Del Giglio A, et al. Quantitative expression of proliferating cell nuclear antigen by western blot (PCNAWB) in peripheral blasts correlates with remission induction in patients with acute myelogenous leukemia. Leuk Lymphoma. 1995 Oct; 19(3-4):235-41. PMID: 8535214.
      Citations: 1     Fields:    Translation:Humans
    230. Vadhan-Raj S, Broxmeyer HE, Andreeff M, Bandres JC, Buescher ES, Benjamin RS, Papadopoulos NE, Burgess A, Patel S, Plager C, Hittelman WN, McAlister I, Garrison L, Williams DE. In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study. Blood. 1995 Sep 15; 86(6):2098-105. PMID: 7662957.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    231. Patel SR, Benjamin RS. Primary extraskeletal osteosarcoma--experience with chemotherapy. J Natl Cancer Inst. 1995 Sep 06; 87(17):1331-3. PMID: 7658488.
      Citations: 11     Fields:    Translation:Humans
    232. Jaffe N, Patel SR, Benjamin RS. Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation. Hematol Oncol Clin North Am. 1995 Aug; 9(4):825-40. PMID: 7490244.
      Citations: 4     Fields:    Translation:Humans
    233. Patel SR, Burgess MA, Papadopoulos NE, Linke KA, Benjamin RS. Extraskeletal myxoid chondrosarcoma. Long-term experience with chemotherapy. Am J Clin Oncol. 1995 Apr; 18(2):161-3. PMID: 7900708.
      Citations: 20     Fields:    Translation:Humans
    234. Patel SR, Burgess MA, Plager C, Papadopoulos NE, Linke KA, Benjamin RS. Myxoid liposarcoma. Experience with chemotherapy. Cancer. 1994 Aug 15; 74(4):1265-9. PMID: 8055448.
      Citations: 33     Fields:    Translation:Humans
    235. Vadhan-Raj S, Papadopoulos NE, Burgess MA, Linke KA, Patel SR, Hays C, Arcenas A, Plager C, Kudelka AP, Hittelman WN, et al. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma. J Clin Oncol. 1994 Apr; 12(4):715-24. PMID: 8151315.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    236. Lynch HT, Fitzgibbons R, Chong S, Cavalieri J, Lynch J, Wallace F, Patel S. Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum. 1994 Mar; 37(3):260-7. PMID: 8137673.
      Citations: 18     Fields:    Translation:Humans
    237. Patel SR, Forman AD, Benjamin RS. High-dose ifosfamide-induced exacerbation of peripheral neuropathy. J Natl Cancer Inst. 1994 Feb 16; 86(4):305-6. PMID: 8158686.
      Citations:    Fields:    Translation:Humans
    238. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp Hematol. 1994 Jan; 22(1):100-2. PMID: 7506671.
      Citations: 3     Fields:    Translation:HumansCells
    239. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer. 1993 Dec 01; 72(11):3244-7. PMID: 8242548.
      Citations: 44     Fields:    Translation:Humans
    240. Benjamin RS, Legha SS, Patel SR, Nicaise C. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience. Cancer Chemother Pharmacol. 1993; 31 Suppl 2:S174-9. PMID: 8453693.
      Citations: 9     Fields:    Translation:Humans
    241. Benjamin RS, Chawla SP, Carrasco CH, Raymond AK, Murray JA, Armen T, Patel S, Wallace S, Ayala A, Papadopoulos NE, et al. Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum. Ann Oncol. 1992 Apr; 3 Suppl 2:S3-6. PMID: 1622860.
      Citations: 4     Fields:    Translation:Humans
    242. Patel S, Benjamin RS. Standard and high dose chemotherapy for advanced soft tissue sarcomas. Ann Oncol. 1992 Apr; 3 Suppl 2:S81-3. PMID: 1622875.
      Citations: 1     Fields:    Translation:Humans
    243. Laurie JA, Hahn RG, Therneau TM, Patel SR, Mailliard JA, Windschitl HE, Twito DI, Morton RF, Krook JE. Chemotherapy for hormonally refractory advanced prostate carcinoma. A comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil. Cancer. 1992 Mar 15; 69(6):1440-4. PMID: 1540881.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    244. Patel SR, Buckner JC, Smithson WA, Scheithauer BW, Groover RV. Cisplatin-based chemotherapy in primary central nervous system germ cell tumors. J Neurooncol. 1992 Jan; 12(1):47-52. PMID: 1541978.
      Citations: 10     Fields:    Translation:Humans
    245. Patel SR, Kvols LK, Rubin J, O'Connell MJ, Edmonson JH, Ames MM, Kovach JS. Phase I-II study of pibenzimol hydrochloride (NSC 322921) in advanced pancreatic carcinoma. Invest New Drugs. 1991 Feb; 9(1):53-7. PMID: 1709152.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    246. Patel SR, Richardson RL, Kvols L, Zincke H. Observation after orchiectomy in clinical stage I nonseminomatous germ cell tumor of testis. Mayo Clinic experience. Am J Clin Oncol. 1990 Oct; 13(5):379-81. PMID: 2171316.
      Citations:    Fields:    Translation:Humans
    247. Ransom DT, Patel SR, Keeney GL, Malkasian GD, Edmonson JH. Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy. Cancer. 1990 Sep 15; 66(6):1091-4. PMID: 2400962.
      Citations: 8     Fields:    Translation:Humans
    248. Patel SR, Kvols LK, Hahn RG, Windschitl H, Levitt R, Therneau T. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer. 1990 Aug 15; 66(4):655-8. PMID: 2201425.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    249. Patel SR, Kvols LK, Richardson RL. Familial testicular cancer: report of six cases and review of the literature. Mayo Clin Proc. 1990 Jun; 65(6):804-8. PMID: 2195242.
      Citations: 3     Fields:    Translation:Humans
    250. Patel SR, Richardson RL, Kvols L. Synchronous and metachronous bilateral testicular tumors. Mayo Clinic experience. Cancer. 1990 Jan 01; 65(1):1-4. PMID: 2293856.
      Citations: 13     Fields:    Translation:Humans
    251. Patel SR, Kvols LK, Peterson DA, Gilbertson DT, Moertel CG, O'Dorisio TM. Comparison of the pharmacokinetics of octreotide injected at two subcutaneous sites. J Natl Cancer Inst. 1989 Dec 20; 81(24):1926-9. PMID: 2593172.
      Citations: 1     Fields:    Translation:Humans
    252. Patel SR, Richardson RL, Kvols L. Metastatic cancer to the testes: a report of 20 cases and review of the literature. J Urol. 1989 Oct; 142(4):1003-5. PMID: 2677407.
      Citations: 25     Fields:    Translation:Humans
    253. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer.
    254. Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma?. Journal of Computer Assisted Tomography.
    255. Antitumor response of VEGFR2- and VEGFR3-amplified angiosarcoma to pazopanib. JNCCN Journal of the National Comprehensive Cancer Network. 14:499-502.
    256. Soft tissue sarcomas. 311-318.
    257. Benign Tumours of the Spine. Spine.
    258. Treatment of recurrent soft tissue sarcoma. Problems in General Surgery. 16:73-83.
    259. Chemotherapy for soft-tissue sarcomas. ONCOLOGY (United States). 29.
    260. Cancer Chemotherapy and Pharmacology. Cancer Chemotherapy and Pharmacology. 67.
    261. Soft Tissue Sarcomas. 696-703.
    262. Assessment of the tumour viability by diffusion-weighted MR imaging. Clinical MRI. 11:75-78.
    263. An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients. Current Oncology Reports. 18.
    264. Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney. American Journal of Clinical Oncology: Cancer Clinical Trials.
    265. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. 7:64421-64430.
    266. Erratum. Current Oncology Reports. 14:220.
    267. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?. Clinical Orthopaedics and Related Research. 473:3604-3611.
    268. Survival of patients with metastatic leiomyosarcoma. Cancer Medicine. 5:3437-3444.
    269. Clinical Decision Making. Spine.
    270. Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. Oncotarget. 7:67521-67531.
    271. STUMP un"stumped". Journal of Hematology and Oncology. 8.
    272. Assessing the role of 18F-FDG PET and 18F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies. European Journal of Nuclear Medicine and Molecular Imaging. 1-11.
    273. Primary retroperitoneal tumors. 403-421.
    274. Assessment of imaging modalities and response metrics in Ewing sarcoma. Journal of Clinical Oncology. 34:3680-3685.
    275. Chemotherapy for bone sarcoma in adults. Journal of Oncology Practice. 12:208-216.
    276. Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer. Journal of Clinical Neuroscience. 34:15-22.
    277. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Scientific Reports. 6.
    278. SARC009. Cancer. 122:868-874.
    279. Adult versus pediatric neuroblastoma. Sarcoma. 2014.
    PATEL's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (544)
    Explore
    _
    Co-Authors (132)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _